Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review

Stefano Palomba; Caterina Materazzo; Angela Falbo; Francesco Orio; Giovanni Battista La Sala; Charles Sultan

doi:10.3109/09513590.2013.876001

Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review

Stefano Palomba, Caterina Materazzo, Angela Falbo, Francesco Orio, Giovanni Battista La Sala, Charles Sultan

Research output: Contribution to journal › Article › peer-review

Abstract

The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.

Original language	English
Pages (from-to)	335-340
Number of pages	6
Journal	Gynecological Endocrinology
Volume	30
Issue number	5
DOIs	https://doi.org/10.3109/09513590.2013.876001
Publication status	Published - 2014

Keywords

Adolescents
Metformin
Oligo-amenorrhea
Oral contraceptives
PCOS

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism
Obstetrics and Gynaecology
Medicine(all)

Access to Document

10.3109/09513590.2013.876001

Cite this

Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review. / Palomba, Stefano; Materazzo, Caterina; Falbo, Angela; Orio, Francesco; La Sala, Giovanni Battista; Sultan, Charles.

In: Gynecological Endocrinology, Vol. 30, No. 5, 2014, p. 335-340.

Research output: Contribution to journal › Article › peer-review

@article{7d0554cdbc3c439bae6504583f4cf836,

title = "Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review",

abstract = "The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.",

keywords = "Adolescents, Metformin, Oligo-amenorrhea, Oral contraceptives, PCOS",

author = "Stefano Palomba and Caterina Materazzo and Angela Falbo and Francesco Orio and {La Sala}, {Giovanni Battista} and Charles Sultan",

year = "2014",

doi = "10.3109/09513590.2013.876001",

language = "English",

volume = "30",

pages = "335--340",

journal = "Gynecological Endocrinology",

issn = "0951-3590",

publisher = "Informa Healthcare",

number = "5",

}

TY - JOUR

T1 - Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review

AU - Palomba, Stefano

AU - Materazzo, Caterina

AU - Falbo, Angela

AU - Orio, Francesco

AU - La Sala, Giovanni Battista

AU - Sultan, Charles

PY - 2014

Y1 - 2014

N2 - The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.

AB - The management of oligo-amenorrhea in adolescent patients with polycystic ovary syndrome (PCOS) represents an important and difficult challenge. Metformin and/or oral contraceptives (OCs) are different strategies widely proposed in these patients. The objective of the current review was to provide an overview on the use of metformin and/or OCs for the management of oligo-amenorrhea in adolescents with PCOS underlining their potential risks and benefits in order to help the clinician to choose the best patients' tailored treatment.

KW - Adolescents

KW - Metformin

KW - Oligo-amenorrhea

KW - Oral contraceptives

KW - PCOS

UR - http://www.scopus.com/inward/record.url?scp=84898849962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898849962&partnerID=8YFLogxK

U2 - 10.3109/09513590.2013.876001

DO - 10.3109/09513590.2013.876001

M3 - Article

C2 - 24405081

AN - SCOPUS:84898849962

VL - 30

SP - 335

EP - 340

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 5

ER -

Metformin, oral contraceptives or both to manage oligo-amenorrhea in adolescents with polycystic ovary syndrome? A clinical review

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this